132-35-4 YR02IKM54O Proxazole citrate Proxazole citrate [USAN] 5-(2-(Diethylammonio)ethyl)-3-(1-phenylpropyl)-1,2,4-oxadiazolediylium citrate 1,2,4-Oxadiazole, 5-(2-(diethylamino)ethyl)-3-(alpha-ethylbenzyl)-, citrate 1,2,4-Oxadiazole-5-ethanamine, N,N-diethyl-3-(1-phenylpropyl)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) Aerbron AF-634 5-(2-(Diethylamino)ethyl)-3-(alpha-ethylbenzyl)-1,2,4-oxadiazole citrate 5-(2-(Diethylamino)ethyl)-3-(alpha-ethylbenzyl)-1,2,4-oxadiazole citrate (1:1) 5-(2-(Diethylamino)ethyl)-3-(alpha-phenylpropyl)-1,2,4-oxadiazole citrate N,N-Diethyl-3-(1-phenylpropyl)-1,2,4-oxadiazole-5-ethanamine citrate EINECS 205-059-8 Flou NSC 303872 1,2,4-Oxadiazole-5-ethanamine, N,N-diethyl-3-(1-phenylpropyl)-, citrate 3-alpha-Phenylpropyl-5-beta-diethylaminoethyl-1,2,4-oxadiazole citrate Pirecin Propaxolin citrate Propaxoline citrate Solacil Toness UNII-YR02IKM54O CAS 132-35-4

Purity 97%+In StockPharmaceutical Standards
CAS No.132-35-4
Molecular FormulaC17H25N3O C6H8O7
Molecular WeightN/A
CategoryPharmaceutical Standards / API Standards
AvailabilityIn Stock

Chemical Structure

132-35-4 YR02IKM54O Proxazole citrate Proxazole citrate [USAN] 5-(2-(Diethylammonio)ethyl)-3-(1-phenylpropyl)-1,2,4-oxadiazolediylium citrate 1,2,4-Oxadiazole, 5-(2-(diethylamino)ethyl)-3-(alpha-ethylbenzyl)-, citrate 1,2,4-Oxadiazole-5-ethanamine, N,N-diethyl-3-(1-phenylpropyl)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) Aerbron AF-634 5-(2-(Diethylamino)ethyl)-3-(alpha-ethylbenzyl)-1,2,4-oxadiazole citrate 5-(2-(Diethylamino)ethyl)-3-(alpha-ethylbenzyl)-1,2,4-oxadiazole citrate (1:1) 5-(2-(Diethylamino)ethyl)-3-(alpha-phenylpropyl)-1,2,4-oxadiazole citrate N,N-Diethyl-3-(1-phenylpropyl)-1,2,4-oxadiazole-5-ethanamine citrate EINECS 205-059-8 Flou NSC 303872 1,2,4-Oxadiazole-5-ethanamine, N,N-diethyl-3-(1-phenylpropyl)-, citrate 3-alpha-Phenylpropyl-5-beta-diethylaminoethyl-1,2,4-oxadiazole citrate Pirecin Propaxolin citrate Propaxoline citrate Solacil Toness UNII-YR02IKM54O CAS 132-35-4 chemical structure

Description

Order 132-35-4 YR02IKM54O Proxazole citrate Proxazole citrate [USAN] 5-(2-(Diethylammonio)ethyl)-3-(1-phenylpropyl)-1,2,4-oxadiazolediylium citrate 1,2,4-Oxadiazole, 5-(2-(diethylamino)ethyl)-3-(alpha-ethylbenzyl)-, citrate 1,2,4-Oxadiazole-5-ethanamine, N,N-diethyl-3-(1-phenylpropyl)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) Aerbron AF-634 5-(2-(Diethylamino)ethyl)-3-(alpha-ethylbenzyl)-1,2,4-oxadiazole citrate 5-(2-(Diethylamino)ethyl)-3-(alpha-ethylbenzyl)-1,2,4-oxadiazole citrate (1:1) 5-(2-(Diethylamino)ethyl)-3-(alpha-phenylpropyl)-1,2,4-oxadiazole citrate N,N-Diethyl-3-(1-phenylpropyl)-1,2,4-oxadiazole-5-ethanamine citrate EINECS 205-059-8 Flou NSC 303872 1,2,4-Oxadiazole-5-ethanamine, N,N-diethyl-3-(1-phenylpropyl)-, citrate 3-alpha-Phenylpropyl-5-beta-diethylaminoethyl-1,2,4-oxadiazole citrate Pirecin Propaxolin citrate Propaxoline citrate Solacil Toness UNII-YR02IKM54O (CAS 132-35-4) pharmaceutical standards reference standard from CATO: ISO 17034 accredited producer, 130,000+ catalog items in stock. Molecular formula: C17H25N3O C6H8O7. COA included with every batch.

Physical & Chemical Properties

Molecular FormulaC17H25N3O C6H8O7
Molecular Weight479.53 g/mol
AppearancePale yellow to yellow crystalline powder
Purity97%+
StorageStore in a cool place (≤25°C), protect from light, keep sealed and dry
Solubility (reference)Soluble in DMSO, DMF, methanol
StabilityMay oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening
Degree of Unsaturation (DBE)9.0
UV AbsorptionUV-absorbing
Structural FeaturesAromatic ring present
CAS Registry Year (est.)1957
Nitrogen Atoms3

Recommended Standards

Why CATO?